Apolipoprotein B (ApoB): A New Approach to Heart Attack Prevention
Heart disease remains the leading cause of death worldwide, with atherosclerosis and its complications—such as heart attacks and strokes—driving much of this burden. For decades, clinicians have relied on low-density lipoprotein cholesterol (LDL-C) as the primary biomarker to assess cardiovascular risk and guide treatment decisions. Although, growing evidence suggests that apolipoprotein B (ApoB), a structural … Read more